CYCC   $6.365  -5.98% Market Closed

Cyclacel Pharmaceuticals, Inc.
Total Cash 6.00M
totalCashPerShare 3.039
EBITDA -20.18M
Total Debt 5.00K
quickRatio 0.97
currentRatio 1.073
Total Revenue 80.00K
debtToEquity 0.501
Revenue/Share 0.044
ROA -1.02529
ROE -5.70693
grossProfits
freeCashflow -7.66M
operatingCashflow -11.51M
earningsGrowth
revenueGrowth -0.989
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -911.0
profitMargins 0.0
enterpriseValue -5.18M
forwardPE -0.20859297
floatShares 1.76M
sharesOutstanding 2.15M
sharesShort 36.49K
sharesShortPriorMonth 47.64K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.18%
Short Ratio help_outline 1.10%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.553
Price To Book help_outline 0.75
earningsQuarterlyGrowth
netIncomeToCommon -17.61M
trailingEps -15.31%
forwardEps -1.99%
enterpriseToEbitda 0.26
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.55 3Q 2024
institutionsCount 19
lastUpdated Nov. 7, 2024, 9:24 a.m.